Medidata NEXT Tokyo to Showcase Transformative Innovations Reshaping the Clinical Trials Landscape
Event brings together biopharma leaders to chart a new course for the faster delivery of new therapies to patients in Japan
TOKYO, Japan, Sept. 11, 2024 - Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, is hosting NEXT Tokyo 2024 at The Westin Tokyo today. Bringing together more than 500 industry leaders, the event provides a platform to discuss new innovations in clinical trial design and execution, including the biggest challenges and opportunities. NEXT Tokyo is also showcasing technologies such as Medidata’s Clinical Data Studio solution, the enhanced usability of the Medidata Platform, and the use of virtual twins and generative AI across the value chain — from research through commercialization.
This year’s event marks the 11th anniversary of NEXT Tokyo. It features more than 25 speakers, including representatives from Chugai Pharma, Daiichi Sankyo, and Senju Pharma. Attendees will explore how Medidata and its partners are transforming the clinical landscape, and enabling life sciences companies to deliver treatments to patients sooner.
The event also includes interactive sessions and immersive experiences, providing participants with hands-on opportunities to engage in a simulated decentralized clinical trial journey and interact with Medidata’s industry-leading data management systems.
“NEXT Tokyo 2024 is one of the region’s premier industry events, demonstrating how transformative solutions, including AI, are reshaping the clinical trial landscape,” said Motohide Nishi, vice president, Japan Sales, Medidata. “As we celebrate Medidata’s 25th anniversary, we look forward to continuing to provide our insights on new technologies and digital innovations that are empowering customers and helping to expedite the delivery of life-changing therapies to patients in Japan.”
For this year’s event, Medidata has partnered with another Dassault Systèmes brand, BIOVIA, to showcase a portfolio of digital solutions across the entire lifecycle of the life sciences industry. This includes demonstrating several cutting-edge technologies, from drug discovery and laboratory quality management to manufacturing and quality improvement.
About Medidata
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.